Covista (CVSA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Covista

NYSE•Consumer Defensive•Education & Training Services

$126.72+0.31(<0.01%)Market closed

Market Cap

$4.32B

P/E

17.2x

P/S

2.2x

P/B

3.0x

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. has a strategic collaboration agreement with Advocate Health to expand access to nursing education and build a direct pipeline of practice-ready nurses across the communities Advocate Health serves. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

How this company scores

ExcellentMetricSide Score: 80/100

Strongest: Cash & Earnings Quality (24/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability22/25

Growth19/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality24/25

Strengths

Rising free cash flowStrong marginsHigh ROELow leverage

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 17.2x5y range 4.2x – 21.9x

Currently near its 18-quarter median.

P/S · 2.2x5y range 1.0x – 3.0x

Currently above its 20-quarter median.

P/B · 3.0x5y range 1.0x – 3.8x

Price & Volume

Market Cap $4.32B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.95B
Q. Revenue: $501.38M
TTM EBITDA: $383.38M
TTM Op. Income: $383.38M
Q. Op. Income: $95.44M
TTM Net Income: $251.57M
Q. Net Income: $71.72M
EPS: $2.106
Shares Out.: $34.06M

$1.95B in TTM revenue grew 9.3% YoY, reaching $501.38M last quarter. TTM EBITDA of $383.38M and TTM operating income of $383.38M show growth is flowing through to the bottom line. TTM net income of $251.57M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 56.8%
EBITDA Margin: 19.0%
Op. Margin: 19.0%
Net Margin: 14.3%

Op. margin of 19.0% is up 2.2% YoY — cost efficiency is improving. Net margin at 14.3% and gross margin of 56.8% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 13% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 17.2x
P/S Ratio: 2.2x
P/B Ratio: 3.0x

At 17.2x P/E, the stock trades within typical market levels. P/S of 2.2x and P/B of 3.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.01B
Cash: $406.32M
Long-Term Debt: $657.75M
Book Value: $1.45B
D/E Ratio: 0.5
Debt/EBITDA: 6.9

With $3.01B in assets and $657.75M in long-term debt, D/E is 0.5and book value is $1.45B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 18% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $123.96M
TTM Free Cash Flow: $392.73M
FCF Margin: 20.1%
FCF / Net Income: 1.6

TTM FCF of $392.73M on $123.96M in operating cash flow. The FCF / Net Income ratio of 1.6x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 37% — an improving trend.